Laman UtamaADVM • NASDAQ
Adverum Biotechnologies Inc
$6.99
27 Sep, 3:31:52 PTG GMT-4 · USD · NASDAQ · Penafian
SahamSekuriti tersenarai ASIbu pejabat di AS
Tutup sebelumnya
$6.61
Julat hari
$6.66 - $7.08
Julat tahun
$6.38 - $29.60
Permodalan pasaran
145.29J USD
Bilangan Purata
173.16K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Jun 2024Perubahan T/T
Hasil
——
Perbelanjaan pengendalian
3.78J-69.64%
Pendapatan bersih
-18.48J41.36%
Margin untung bersih
——
Pendapatan bagi setiap syer
-0.8971.29%
EBITDA
-19.93J36.81%
Kadar cukai berkesan
——
Jumlah aset
Jumlah liabiliti
(USD)Jun 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
173.83J22.89%
Jumlah aset
253.80J5.13%
Jumlah liabiliti
85.77J-22.22%
Jumlah ekuiti
168.03J—
Syer tertunggak
20.80J—
Harga kepada buku
0.82—
Pulangan pada aset
-20.02%—
Pulangan pada modal
-20.94%—
Perubahan bersih dalam tunai
(USD)Jun 2024Perubahan T/T
Pendapatan bersih
-18.48J41.36%
Tunai daripada operasi
-19.84J14.65%
Tunai daripada pelaburan
-2.33J-103.47%
Tunai daripada pembiayaan
-116.00K-1,550.00%
Perubahan bersih dalam tunai
-22.29J-150.90%
Aliran tunai bebas
-7.13J57.79%
Perihal
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Diasaskan
1 Jan 2006
Tapak web
Pekerja
121
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama